Effect of a Standardized Moisture-Care Protocol Using Skin Barrier Spray on Prevention of Pressure Injuries in the Perineal-Sacral Area Among Incontinent Inpatients: A 3-month Pilot Study.
1 other identifier
interventional
70
1 country
1
Brief Summary
This pilot study aims to evaluate whether a standardized proactive moisture-care protocol using a silicone-based skin barrier spray can reduce early-stage pressure injuries (PIs) in the perineal-sacral area among incontinent inpatients. Incontinence leads to prolonged exposure of skin to moisture and irritants, resulting in Incontinence-Associated Dermatitis (IAD) and increased vulnerability to PIs. Currently, barrier products are applied reactively after skin redness appears. The proposed intervention introduces a proactive approach-daily application of barrier spray during routine morning care before visible damage occurs. Forty inpatients aged65 or above will be recruited from an acute medical ward over 12weeks. Participants admitted in weeks1-6 will receive usual care (control), and those in weeks7-12 will receive the proactive protocol (intervention). Each will be observed for up to14days or until discharge or skin breakdown. The primary outcome is the incidence of new Stage1-2PIs in the perineal-sacral area; secondary outcomes include IAD incidence, nursing compliance, workload, and cost comparisons. This minimal-risk study uses only approved hospital products, follows standard hygiene and safety procedures, and emphasizes proactive prevention to enhance patient outcomes, nursing efficiency, and resource sustainability. Results will guide future large-scale implementation of standardized moisture-care practices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 20, 2026
CompletedFirst Submitted
Initial submission to the registry
September 25, 2026
CompletedFirst Posted
Study publicly available on registry
October 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 4, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2026
October 1, 2026
September 1, 2026
3 months
September 25, 2026
September 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of New Stage 1-2 Perineal-Sacral Pressure Injuries
Percentage of participants who develop a new Stage 1 or Stage 2 pressure injury in the perineal-sacral area, classified using the NPIAP Pressure Injury Staging System.
Up to 14 days (from admission until hospital discharge or first sign of skin breakdown, whichever occurs first)
Study Arms (2)
Usual care
ACTIVE COMPARATORThis arm receives active usual care (standard cleansing + reactive application of barrier creams upon early signs of redness).
Intervention Group
EXPERIMENTALStandard moisture care protocol with proactive daily application of Skin Barrier spray every morning to intact perineal-sacral skin. Observation lasts up to 14 days, until hospital discharge, or until skin breakdown occurs.
Interventions
Standard reactive nursing care involving no-rinse skin cleansing, with skin barrier products (zinc oxide or barrier cream) applied only upon clinical identification of early skin redness or irritation.
A proactive moisture-care protocol comprising routine no-rinse skin cleansing and once-daily application of a silicone-based skin barrier spray every morning following incontinence care to all intact perineal-sacral skin.
Eligibility Criteria
You may qualify if:
- Aged 65 years or older.
- Braden Scale total score of 18 or below at admission screening.
- Presence of urinary incontinence, fecal incontinence, or both, requiring napkin use.
- Intact perineal-sacral skin at the time of enrolment.
You may not qualify if:
- Presence of an indwelling urinary catheter.
- Active diarrhea at the time of screening.
- Documented allergy or sensitivity to skin barrier products.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
United Christian Hospital
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Advanced Practice Nurse
Study Record Dates
First Submitted
September 25, 2026
First Posted
October 1, 2026
Study Start
July 20, 2026
Primary Completion (Estimated)
October 4, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
October 1, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share